These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 1197141)

  • 1. Analysis of the hypotensive action of prazosin.
    Constantine JW; McShane WK; Scriabine A; Hess HJ
    Postgrad Med; 1975 Nov; Spec No():18-35. PubMed ID: 1197141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of atenolol with the systemic and regional hemodynamic effects of hydralazine in conscious renal hypertensive rabbits.
    Bolt GR; Saxena PR
    J Pharmacol Exp Ther; 1984 Jul; 230(1):205-13. PubMed ID: 6747826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A three-phase clinical evaluation of prazosin.
    Smith IS; Fernandes M; Kim KE; Swartz C; Onesti G
    Postgrad Med; 1975 Nov; Spec No():53-60. PubMed ID: 1105485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacological effects of an unusual hypotensive agent: (SK & F 11197, 2,6-diamino-4-dimethylamino-ethoxy pyrimidine). I. Effects on the cardiovascular system.
    Ehrreich SJ; Heringslake JE; Warren FR; Weinstock J; Tedeschi RE
    Arch Int Pharmacodyn Ther; 1969 Jun; 179(2):284-302. PubMed ID: 5367304
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodynamic changes at rest and during exercise in long-term prazosin therapy for essential hypertension.
    Lund-Johansen P
    Postgrad Med; 1975 Nov; Spec No():45-52. PubMed ID: 1197143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypotensive action of DL-(methylene-3-4) phenyl 2 hydroxy-2-acetamidine hydrocloride (LL-1418)].
    Duteil J; Sautai M; Pessonnier A; Gombert R; Assous E
    Therapie; 1969; 24(4):723-33. PubMed ID: 5822010
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic and coronary hemodynamic effects of pinacidil, a new antihypertensive agent, in awake dogs: comparison with hydralazine.
    Kawashima S; Liang CS
    J Pharmacol Exp Ther; 1985 Feb; 232(2):369-75. PubMed ID: 3968638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on the influence of the antihypertensive drug urapidil on blood circulation and its regulation in animal experiments (author's transl)].
    Schoetensack W; Bischler P; Dittmann EC; Steinijans V
    Arzneimittelforschung; 1977; 27(10):1908-19. PubMed ID: 579101
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular effects of losulazine hydrochloride, a peripheral norepinephrine-depleting agent, in nonhuman primates.
    Pals DT; DeGraaf GL
    J Pharmacol Exp Ther; 1985 Feb; 232(2):407-12. PubMed ID: 3968642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of reflex tachycardia by central administration of the alpha-1 adrenoceptor antagonists urapidil and prazosin in anesthetized dogs.
    Shebuski RJ; Zimmerman BG
    J Pharmacol Exp Ther; 1985 Aug; 234(2):456-62. PubMed ID: 2862276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypotensive and cardiovascular action of budralazine in unanesthetized and unrestrained dogs.
    Konno K; Nonaka K; Ueno A
    Arzneimittelforschung; 1981; 31(7):1072-5. PubMed ID: 7196755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular profile and hypotensive mechanism of ketanserin in the rabbit.
    Bolt GR; Saxena PR
    Hypertension; 1985; 7(4):499-506. PubMed ID: 2861161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hypotensive effect of trimazosin is not caused solely by alpha 1-adrenoceptor blockade.
    Constantine JW; Lebel W; Weeks R
    J Cardiovasc Pharmacol; 1984; 6(1):142-50. PubMed ID: 6199597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional blood flow and cardiac responses to hydralazine.
    Spokas EG; Wang HH
    J Pharmacol Exp Ther; 1980 Feb; 212(2):294-303. PubMed ID: 7351643
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular effects of a novel vasoactive antihypertensive agent, Ro 12-4713.
    Gerold M; Eigenmann R; Hefti F; Daum A; Haeusler G
    J Pharmacol Exp Ther; 1981 Mar; 216(3):624-33. PubMed ID: 7009831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of Go-1002.
    Grewal RS; Kaul CL; David J
    J Pharmacol Exp Ther; 1968 Apr; 160(2):268-76. PubMed ID: 4384786
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of the hypotensive action of prazosin.
    Oates HF; Graham RM; Stokes GS
    Arch Int Pharmacodyn Ther; 1977 May; 227(1):41-8. PubMed ID: 901072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative profile of L 3428 and other antianginal agents on cardiac hemodynamics.
    Petta JM; Zaccheo VJ
    J Pharmacol Exp Ther; 1971 Feb; 176(2):328-38. PubMed ID: 4998691
    [No Abstract]   [Full Text] [Related]  

  • 19. Prazosin: biochemistry and structure-activity studies.
    Hess HJ
    Postgrad Med; 1975 Nov; Spec No():9-17. PubMed ID: 172877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of the hypotensive effect of prazosin.
    Scivoletto R; Toledo AJ; Gomes da Silva AC; Nigro D
    Arch Int Pharmacodyn Ther; 1976 Oct; 223(2):333-8. PubMed ID: 999414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.